An	O
11-base-pair	O
DNA	O
sequence	O
motif	O
apparently	O
unique	O
to	O
the	O
human	B-DNA
interleukin	I-DNA
4	I-DNA
gene	I-DNA
confers	O
responsiveness	O
to	O
T-cell	O
activation	O
signals	O
.	O

We	O
have	O
identified	O
a	O
DNA	B-DNA
segment	I-DNA
that	O
confers	O
responsiveness	O
to	O
antigen	O
stimulation	O
signals	O
on	O
the	O
human	B-DNA
interleukin	I-DNA
(	I-DNA
IL	I-DNA
)	I-DNA
4	I-DNA
gene	I-DNA
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

The	O
human	B-DNA
IL-4	I-DNA
gene	I-DNA
,	O
of	O
10	O
kilobases	O
,	O
is	O
composed	O
of	O
four	O
exons	B-DNA
and	O
three	O
introns	B-DNA
.	O

A	O
cis-acting	B-DNA
element	I-DNA
(	O
P	B-DNA
sequence	I-DNA
)	O
resides	O
in	O
the	O
5	B-DNA
'	I-DNA
upstream	I-DNA
region	I-DNA
;	O
no	O
additional	O
DNA	B-DNA
segments	I-DNA
with	O
enhancer	O
activity	O
were	O
identified	O
in	O
the	O
human	B-DNA
IL-4	I-DNA
gene	I-DNA
.	O

For	O
further	O
mapping	O
purposes	O
,	O
a	O
fusion	B-DNA
promoter	I-DNA
was	O
constructed	O
with	O
the	O
granulocyte/macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
basic	I-DNA
promoter	I-DNA
containing	O
60	B-DNA
base	I-DNA
pairs	I-DNA
of	I-DNA
sequence	I-DNA
upstream	O
from	O
the	O
cap	B-DNA
site	I-DNA
of	O
the	O
mouse	B-DNA
granulocyte/macrophage	I-DNA
colony-stimulating	I-DNA
factor	I-DNA
gene	I-DNA
and	O
various	O
lengths	O
of	O
the	O
5	B-DNA
'	I-DNA
upstream	I-DNA
sequence	I-DNA
of	O
the	O
IL-4	B-DNA
gene	I-DNA
.	O

The	O
P	B-DNA
sequence	I-DNA
was	O
located	O
between	O
positions	O
-79	O
and	O
-69	O
relative	O
to	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
of	O
the	O
human	B-DNA
IL-4	I-DNA
gene	I-DNA
,	O
and	O
this	O
location	O
was	O
confirmed	O
by	O
base-substitution	O
mutations	O
.	O

The	O
plasmids	O
carrying	O
multiple	O
copies	O
of	O
the	O
P	B-DNA
sequence	I-DNA
showed	O
higher	O
responsiveness	O
to	O
the	O
stimulation	O
.	O

The	O
binding	B-protein
protein	I-protein
(	O
s	O
)	O
that	O
recognize	O
the	O
P	B-DNA
sequence	I-DNA
of	O
the	O
IL-4	B-DNA
gene	I-DNA
were	O
identified	O
by	O
DNA-mobility-shift	O
assays	O
.	O

The	O
binding	O
of	O
NF	B-protein
(	I-protein
P	I-protein
)	I-protein
(	O
a	O
DNA	B-protein
binding	I-protein
protein	I-protein
that	O
specifically	O
recognizes	O
the	O
P	B-DNA
sequence	I-DNA
)	O
to	O
the	O
P	B-DNA
sequence	I-DNA
was	O
abolished	O
when	O
oligonucleotides	O
carrying	O
base	O
substitutions	O
were	O
used	O
,	O
indicating	O
that	O
the	O
NF	B-protein
(	I-protein
P	I-protein
)	I-protein
interaction	O
is	O
sequence-specific	O
and	O
that	O
binding	O
specificity	O
of	O
the	O
protein	O
paralleled	O
the	O
sequence	O
requirements	O
for	O
IL-4	B-protein
expression	O
in	O
vivo	O
.	O

The	O
P	B-DNA
sequence	I-DNA
does	O
not	O
share	O
homology	O
with	O
the	O
5	B-DNA
'	I-DNA
upstream	I-DNA
sequence	I-DNA
of	O
the	O
IL-2	B-DNA
gene	I-DNA
,	O
even	O
though	O
surrounding	O
sequences	O
of	O
the	O
IL-4	B-DNA
gene	I-DNA
share	O
high	O
homology	O
with	O
the	O
IL-2	B-DNA
gene	I-DNA
.	O

We	O
conclude	O
that	O
a	O
different	O
set	O
of	O
proteins	B-protein
recognize	O
IL-2	B-DNA
and	I-DNA
IL-4	I-DNA
genes	I-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

89	NULL
,	NULL
pp	NULL
.	NULL

2864-2868	NULL
,	NULL
April	NULL
1992	NULL
Immunology	NULL
An	NULL
11-base-pair	NULL
DNA	NULL
sequence	NULL
motif	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
human	NULL
interleukin	NULL
4	NULL
gene	NULL
confers	NULL
responsiveness	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
(	NULL
type	NULL
II-specific	NULL
lymphokine	NULL
factors	NULL
)	NULL
ETsuko	NULL
AsE**	NULL
,	NULL
RenE	NULL
DE	NULL
WaaL	NULL
MarerYT*	NULL
,	NULL
Ixuo	NULL
Matsupa*	NULL
}	NULL
,	NULL
Ken-1cHI	NULL
ARAI	NULL
}	NULL
,	NULL
anD	NULL
NaoKO	NULL
Ara1*§	NULL
*Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
901	NULL
California	NULL
Avenue	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
94304-1104	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
The	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
4-6-1	NULL
,	NULL
Shirokanedai	NULL
,	NULL
Minato-ku	NULL
,	NULL
Tokyo	NULL
108	NULL
,	NULL
Japan	NULL
Communicated	NULL
by	NULL
Kimishige	NULL
Ishizaka	NULL
,	NULL
December	NULL
8	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
We	NULL
have	NULL
identified	NULL
a	NULL
DNA	NULL
segment	NULL
that	NULL
confers	NULL
responsiveness	NULL
to	NULL
antigen	NULL
stimulation	NULL
signals	NULL
on	NULL
the	NULL
human	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
4	NULL
gene	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
human	NULL
IL-4	NULL
gene	NULL
,	NULL
of	NULL
10	NULL
kilobases	NULL
,	NULL
is	NULL
composed	NULL
of	NULL
four	NULL
exons	NULL
and	NULL
three	NULL
introns	NULL
.	NULL

A	NULL
cis-acting	NULL
element	NULL
(	NULL
P	NULL
sequence	NULL
)	NULL
resides	NULL
in	NULL
the	NULL
5	NULL
upstream	NULL
region	NULL
;	NULL
no	NULL
additional	NULL
DNA	NULL
segments	NULL
with	NULL
enhancer	NULL
activity	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
.	NULL

For	NULL
further	NULL
mapping	NULL
purposes	NULL
,	NULL
a	NULL
fusion	NULL
promoter	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
basic	NULL
promoter	NULL
containing	NULL
60	NULL
base	NULL
pairs	NULL
of	NULL
sequence	NULL
upstream	NULL
from	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
mouse	NULL
granulocyte	NULL
/macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
and	NULL
various	NULL
lengths	NULL
of	NULL
the	NULL
5	NULL
'	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
was	NULL
located	NULL
between	NULL
positions	NULL
-79	NULL
and	NULL
-69	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
,	NULL
and	NULL
this	NULL
location	NULL
was	NULL
confirmed	NULL
by	NULL
base-substitution	NULL
mutations	NULL
.	NULL

The	NULL
plasmids	NULL
carrying	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
showed	NULL
higher	NULL
responsiveness	NULL
to	NULL
the	NULL
stimulation	NULL
.	NULL

The	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
recognize	NULL
the	NULL
P	NULL
sequence	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
were	NULL
identified	NULL
by	NULL
DNA-mobility-shift	NULL
assays	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
(	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
P	NULL
sequence	NULL
)	NULL
to	NULL
the	NULL
P	NULL
sequence	NULL
was	NULL
abolished	NULL
when	NULL
oligonucleotides	NULL
carrying	NULL
base	NULL
substitutions	NULL
were	NULL
used	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
interaction	NULL
is	NULL
sequence-specific	NULL
and	NULL
that	NULL
binding	NULL
specificity	NULL
of	NULL
the	NULL
protein	NULL
paralleled	NULL
the	NULL
sequence	NULL
requirements	NULL
for	NULL
IL-4	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
does	NULL
not	NULL
share	NULL
homology	NULL
with	NULL
the	NULL
5°	NULL
upstream	NULL
sequence	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
even	NULL
though	NULL
surrounding	NULL
sequences	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
share	NULL
high	NULL
homology	NULL
with	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
a	NULL
different	NULL
set	NULL
of	NULL
proteins	NULL
recognize	NULL
IL-2	NULL
and	NULL
IL-4	NULL
genes	NULL
.	NULL

cDNA	NULL
cloning	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
4	NULL
documented	NULL
that	NULL
many	NULL
diverse	NULL
activities	NULL
were	NULL
due	NULL
to	NULL
a	NULL
single	NULL
lymphokine	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
B-cell	NULL
growth	NULL
factor	NULL
activity	NULL
(	NULL
3	NULL
)	NULL
,	NULL
IL-4	NULL
stimulates	NULL
the	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
mast	NULL
cells	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
potent	NULL
costimulator	NULL
of	NULL
proliferation	NULL
of	NULL
immature	NULL
T	NULL
cells	NULL
from	NULL
fetal	NULL
and	NULL
adult	NULL
thymuses	NULL
.	NULL

Of	NULL
particular	NULL
importance	NULL
is	NULL
the	NULL
profound	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
regulation	NULL
of	NULL
IgE	NULL
production	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
isotype	NULL
switching	NULL
.	NULL

IL-4	NULL
strongly	NULL
blocks	NULL
activation	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
by	NULL
IL-2	NULL
but	NULL
enhances	NULL
IL-2-induced	NULL
proliferation	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
IL-4	NULL
is	NULL
a	NULL
powerful	NULL
immune	NULL
modulator	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
refs	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
major	NULL
source	NULL
of	NULL
IL-4	NULL
in	NULL
mice	NULL
is	NULL
the	NULL
T	NULL
,	NULL
,2	NULL
subset	NULL
of	NULL
helper	NULL
T	NULL
(	NULL
T	NULL
,	NULL
)	NULL
cells	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
production	NULL
of	NULL
IL-4	NULL
,	NULL
like	NULL
other	NULL
lymphokines	NULL
,	NULL
is	NULL
induced	NULL
by	NULL
antigen	NULL
or	NULL
mitogen	NULL
stimulation	NULL
.	NULL

Activation	NULL
signals	NULL
are	NULL
transmitted	NULL
through	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
an	NULL
increase	NULL
of	NULL
the	NULL
intracellular	NULL
Ca®*	NULL
concentration	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
two	NULL
signals	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
calcium	NULL
ions	NULL
,	NULL
in	NULL
T-cell	NULL
activation	NULL
has	NULL
been	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

2864	NULL
directly	NULL
demonstrated	NULL
by	NULL
employing	NULL
a	NULL
mutant	NULL
protein	NULL
kinase	NULL
C	NULL
that	NULL
is	NULL
constitutively	NULL
active	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
T-cell	NULL
activation	NULL
signals	NULL
and	NULL
by	NULL
using	NULL
the	NULL
IL-2	NULL
gene	NULL
as	NULL
a	NULL
model	NULL
system	NULL
(	NULL
7	NULL
)	NULL
.	NULL

We	NULL
have	NULL
chosen	NULL
IL-4	NULL
as	NULL
a	NULL
model	NULL
for	NULL
differential	NULL
regulation	NULL
of	NULL
lymphokine	NULL
genes	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
isolated	NULL
mouse	NULL
and	NULL
human	NULL
IL-4	NULL
genomic	NULL
clones	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

IL-4	NULL
is	NULL
a	NULL
single-copy	NULL
gene	NULL
composed	NULL
of	NULL
four	NULL
exons	NULL
and	NULL
three	NULL
introns	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
that	NULL
are	NULL
~6	NULL
and	NULL
10	NULL
kilobases	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
IL-4	NULL
genes	NULL
share	NULL
~85	NULL
%	NULL
homology	NULL
,	NULL
suggesting	NULL
their	NULL
importance	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
IL-4	NULL
expression	NULL
(	NULL
8	NULL
)	NULL
.	NULL

IL-4	NULL
genes	NULL
for	NULL
mice	NULL
and	NULL
humans	NULL
were	NULL
mapped	NULL
on	NULL
chromosomes	NULL
11	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
are	NULL
part	NULL
of	NULL
a	NULL
cluster	NULL
of	NULL
lymphokine	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
IL-3	NULL
,	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
and	NULL
IL-5	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
a	NULL
cis-acting	NULL
sequence	NULL
(	NULL
P	NULL
sequence	NULL
)	NULL
is	NULL
responsible	NULL
for	NULL
receiving	NULL
signals	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
protein	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
is	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
IL-4	NULL
enhancer	NULL
and	NULL
is	NULL
not	NULL
found	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
although	NULL
surrounding	NULL
sequences	NULL
share	NULL
high	NULL
homology	NULL
.	NULL

We	NULL
propose	NULL
different	NULL
sets	NULL
of	NULL
proteins	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
IL-4	NULL
and	NULL
IL-2	NULL
genes	NULL
.	NULL

A	NULL
preliminary	NULL
account	NULL
of	NULL
this	NULL
work	NULL
has	NULL
been	NULL
presented	NULL
(	NULL
12	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Construction	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
pmGMLuc-60	NULL
,	NULL
pmGMLuc-96	NULL
,	NULL
and	NULL
pcDSRa-PX	NULL
has	NULL
been	NULL
described	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Deletion	NULL
mutants	NULL
with	NULL
various	NULL
lengths	NULL
of	NULL
the	NULL
5	NULL
'	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
were	NULL
constructed	NULL
by	NULL
using	NULL
mung	NULL
bean	NULL
nuclease	NULL
,	NULL
yielding	NULL
series	NULL
of	NULL
phIL-4	NULL
plasmids	NULL
.	NULL

Fusion	NULL
promoter	NULL
construction	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
transferring	NULL
various	NULL
lengths	NULL
of	NULL
fragments	NULL
from	NULL
phIL-4	NULL
plasmids	NULL
into	NULL
pmGMLuc-60	NULL
after	NULL
filling-in	NULL
the	NULL
Bg/	NULL
II	NULL
site	NULL
,	NULL
yielding	NULL
of	NULL
pFIL-4	NULL
(	NULL
439	NULL
)	NULL
,	NULL
phIL-4	NULL
(	NULL
297	NULL
)	NULL
,	NULL
phIL-4	NULL
(	NULL
220	NULL
)	NULL
,	NULL
phIL-4	NULL
(	NULL
176	NULL
)	NULL
,	NULL
and	NULL
phIL-4	NULL
(	NULL
63	NULL
)	NULL
.	NULL

The	NULL
pFIL-4	NULL
(	NULL
199	NULL
)	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
Dra	NULL
I	NULL
fragment	NULL
(	NULL
positions	NULL
-199	NULL
to	NULL
-32	NULL
)	NULL
into	NULL
the	NULL
blunt-ended	NULL
Bagi	NULL
II	NULL
site	NULL
of	NULL
pmGMLuc-60	NULL
.	NULL

The	NULL
numbers	NULL
in	NULL
parentheses	NULL
represent	NULL
the	NULL
position	NULL
of	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
.	NULL

The	NULL
region	NULL
between	NULL
positions	NULL
-176	NULL
and	NULL
-64	NULL
was	NULL
divided	NULL
into	NULL
three	NULL
portions	NULL
(	NULL
fragment	NULL
A	NULL
,	NULL
positions	NULL
-176	NULL
to	NULL
-140	NULL
;	NULL
fragment	NULL
B	NULL
,	NULL
positions	NULL
-139	NULL
to	NULL
-101	NULL
;	NULL
fragment	NULL
C	NULL
,	NULL
positions	NULL
-100	NULL
to	NULL
-64	NULL
)	NULL
.	NULL

These	NULL
synthetic	NULL
fragments	NULL
,	NULL
designed	NULL
to	NULL
create	NULL
Abbreviations	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
T	NULL
,	NULL
,	NULL
helper	NULL
T.	NULL
*Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
School	NULL
of	NULL
Dentistry	NULL
,	NULL
Showa	NULL
University	NULL
,	NULL
1-5-8	NULL
Hatanodai	NULL
,	NULL
Shinagawa-ku	NULL
,	NULL
Tokyo	NULL
,	NULL
148	NULL
,	NULL
Japan	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Immunology	NULL
:	NULL
Abe	NULL
et	NULL
al	NULL
.	NULL

Bgl	NULL
II	NULL
cohesive	NULL
ends	NULL
(	NULL
GATC	NULL
)	NULL
at	NULL
the	NULL
5	NULL
end	NULL
,	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
unique	NULL
Bg/	NULL
II	NULL
site	NULL
of	NULL
the	NULL
pmGMLuc-60	NULL
plasmid	NULL
.	NULL

The	NULL
plasmids	NULL
were	NULL
named	NULL
pFIL-4	NULL
(	NULL
A	NULL
)	NULL
,	NULL
pFIL-4	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
pFIL-4	NULL
(	NULL
C	NULL
)	NULL
.	NULL

pFIL4	NULL
(	NULL
-C	NULL
)	NULL
contains	NULL
fragment	NULL
C	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
;	NULL
pFIL-4	NULL
(	NULL
A	NULL
+B	NULL
)	NULL
and	NULL
pFIL-4	NULL
(	NULL
B	NULL
+C	NULL
)	NULL
have	NULL
DNA	NULL
fragments	NULL
spanning	NULL
positions	NULL
-176	NULL
to	NULL
-101	NULL
or	NULL
positions	NULL
-139	NULL
to	NULL
-64	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
N	NULL
(	NULL
GATCCTGGTGTAACGAAAATTTC-CAATGT	NULL
,	NULL
positions	NULL
-88	NULL
to	NULL
-64	NULL
)	NULL
,	NULL
the	NULL
P	NULL
(	NULL
GATCCG-AAAATTTCC	NULL
,	NULL
positions	NULL
-79	NULL
to	NULL
-69	NULL
)	NULL
,	NULL
2P	NULL
(	NULL
GATCCGAAA-ATTTCCGATCCGAAAATTTCC	NULL
)	NULL
,	NULL
3P	NULL
(	NULL
GATCCG-	NULL
AAAATTTCCGATCCGAAAATTTCCGATCCGAAA-ATTITCC	NULL
)	NULL
,	NULL
3P	NULL
,	NULL
;	NULL
(	NULL
GATCCTAAAATITCCGATC-	NULL
CTAAAATTTCCGATCCTAAAATTTCC	NULL
)	NULL
,	NULL
and	NULL
3P	NULL
;	NULL
,	NULL
(	NULL
GATCCGAAAATTTACGATCCGAAAATTTACGATC-CGAAAATTTAC	NULL
)	NULL
oligonucleotides	NULL
were	NULL
inserted	NULL
into	NULL
Bg/	NULL
II	NULL
site	NULL
of	NULL
pmGMLuc-60	NULL
to	NULL
obtain	NULL
pFIL4	NULL
(	NULL
N	NULL
)	NULL
,	NULL
pFIL4	NULL
(	NULL
P	NULL
)	NULL
,	NULL
pFIL-4	NULL
(	NULL
2P	NULL
)	NULL
,	NULL
pFIL-4	NULL
(	NULL
3P	NULL
)	NULL
,	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Transfection	NULL
,	NULL
and	NULL
Luciferase	NULL
Assay	NULL
.	NULL

Trans-fections	NULL
into	NULL
Jurkat	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Transfection	NULL
experiments	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

Luciferase	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extract	NULL
from	NULL
Jurkat	NULL
Cells	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
at	NULL
50	NULL
ng/ml	NULL
plus	NULL
0.5	NULL
uM	NULL
A23187	NULL
(	NULL
PMA/A23187	NULL
)	NULL
for	NULL
2-8	NULL
hr	NULL
for	NULL
large-scale	NULL
preparation	NULL
or	NULL
for	NULL
luciferase	NULL
assay	NULL
before	NULL
harvest	NULL
,	NULL
respectively	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

DNA-Mobility-Shift	NULL
Assay	NULL
.	NULL

The	NULL
mobility-shift	NULL
assay	NULL
was	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
at	NULL
4°C	NULL
in	NULL
89	NULL
mM	NULL
Tris	NULL
borate	NULL
,	NULL
pH	NULL
7.5/2	NULL
mM	NULL
EDTA	NULL
.	NULL

RESULTS	NULL
Regulatory	NULL
Sequence	NULL
(	NULL
s	NULL
)	NULL
Responsible	NULL
for	NULL
Mediating	NULL
PMA/A23187	NULL
Stimulation	NULL
Signals	NULL
are	NULL
Localized	NULL
in	NULL
the	NULL
5	NULL
Upstream	NULL
Region	NULL
.	NULL

As	NULL
we	NULL
reported	NULL
(	NULL
9	NULL
)	NULL
,	NULL
human	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
T-cell	NULL
leukemia	NULL
line	NULL
,	NULL
was	NULL
induced	NULL
upon	NULL
stimulation	NULL
by	NULL
PMA/A23187	NULL
,	NULL
which	NULL
mimics	NULL
antigen	NULL
stimulation	NULL
.	NULL

DNA	NULL
elements	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
by	NULL
virus	NULL
trans-activators	NULL
and	NULL
for	NULL
PMA/	NULL
A23187	NULL
stimulation	NULL
are	NULL
localized	NULL
in	NULL
the	NULL
5	NULL
'	NULL
upstream	NULL
region	NULL
.	NULL

To	NULL
delineate	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
,	NULL
5	NULL
'	NULL
upstream	NULL
fragments	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
GM-CSF	NULL
heterol-ogous	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
60-base-pair	NULL
(	NULL
bp	NULL
)	NULL
sequence	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
.	NULL

After	NULL
transfection	NULL
of	NULL
these	NULL
constructs	NULL
,	NULL
the	NULL
IL-4	NULL
promoter	NULL
activity	NULL
was	NULL
evaluated	NULL
by	NULL
measuring	NULL
firefly	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
luciferase	NULL
activity	NULL
was	NULL
dependent	NULL
upon	NULL
PMA/A23187	NULL
stimulation	NULL
and	NULL
the	NULL
upstream	NULL
sequences	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
cis-acting	NULL
element	NULL
responsible	NULL
for	NULL
induction	NULL
was	NULL
mapped	NULL
between	NULL
positions	NULL
-176	NULL
and	NULL
-63	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
also	NULL
confirmed	NULL
in	NULL
B21	NULL
(	NULL
16	NULL
)	NULL
,	NULL
the	NULL
cloned	NULL
T-cell	NULL
line	NULL
,	NULL
with	NULL
nonfusion	NULL
promoter	NULL
constructs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
11-bp	NULL
Sequence	NULL
(	NULL
P	NULL
Sequence	NULL
)	NULL
Confers	NULL
Responsiveness	NULL
to	NULL
PMA	NULL
Stimulation	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
minimum	NULL
region	NULL
that	NULL
responds	NULL
to	NULL
stimulation	NULL
,	NULL
the	NULL
DNA	NULL
segment	NULL
covering	NULL
positions	NULL
-176	NULL
to	NULL
-64	NULL
was	NULL
divided	NULL
into	NULL
three	NULL
fragments	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
,	NULL
which	NULL
were	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
basic	NULL
promoter	NULL
either	NULL
in	NULL
combinations	NULL
of	NULL
two	NULL
or	NULL
as	NULL
single	NULL
fragments	NULL
.	NULL

Enhancer	NULL
activity	NULL
was	NULL
located	NULL
in	NULL
fragment	NULL
C	NULL
(	NULL
positions	NULL
-100	NULL
to	NULL
-64	NULL
)	NULL
since	NULL
high	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
when	NULL
plasmids	NULL
carrying	NULL
this	NULL
fragment	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
activity	NULL
of	NULL
fragment	NULL
C	NULL
was	NULL
orientation-independent	NULL
.	NULL

The	NULL
induction	NULL
activity	NULL
was	NULL
restored	NULL
also	NULL
when	NULL
fragment	NULL
C	NULL
was	NULL
replaced	NULL
by	NULL
fragments	NULL
N	NULL
and	NULL
P	NULL
,	NULL
which	NULL
cover	NULL
positions	NULL
-88	NULL
to	NULL
-64	NULL
and	NULL
positions	NULL
-79	NULL
to	NULL
-69	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
was	NULL
shown	NULL
clearly	NULL
by	NULL
using	NULL
plasmids	NULL
that	NULL
carry	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
2865	NULL
Table	NULL
1	NULL
.	NULL

Mapping	NULL
cis-acting	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
IL-4	NULL
enhancer	NULL
that	NULL
responds	NULL
to	NULL
PMA/A23187	NULL
using	NULL
fusions	NULL
with	NULL
the	NULL
GM-CSF	NULL
basic	NULL
promoter	NULL
Luciferase	NULL
activity	NULL
,	NULL
units/10	NULL
ug	NULL
of	NULL
protein	NULL
Plasmid	NULL
No	NULL
stimulation	NULL
PMA/A23187	NULL
pmGMLuc-60	NULL
230	NULL
670	NULL
pFIL-4	NULL
(	NULL
63	NULL
)	NULL
240	NULL
710	NULL
pFIL-4	NULL
(	NULL
176	NULL
)	NULL
210	NULL
3080	NULL
pFIL-4	NULL
(	NULL
199	NULL
)	NULL
160	NULL
5120	NULL
pFIL-4	NULL
(	NULL
220	NULL
)	NULL
220	NULL
3500	NULL
pFIL-4	NULL
(	NULL
297	NULL
)	NULL
230	NULL
3440	NULL
pFIL-4	NULL
(	NULL
439	NULL
)	NULL
240	NULL
950	NULL
pFIL-4	NULL
(	NULL
1400	NULL
)	NULL
270	NULL
1100	NULL
pmGMLuc-60	NULL
carries	NULL
a	NULL
DNA	NULL
fragment	NULL
from	NULL
positions	NULL
-60	NULL
to	NULL
+27	NULL
from	NULL
cap	NULL
site	NULL
of	NULL
mouse	NULL
GM-CSF	NULL
gene	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
18	NULL
)	NULL
.	NULL

sequence	NULL
.	NULL

The	NULL
transcription	NULL
activity	NULL
was	NULL
augmented	NULL
3-	NULL
and	NULL
S-fold	NULL
when	NULL
pFIL-4	NULL
(	NULL
2P	NULL
)	NULL
and	NULL
pFIL-4	NULL
(	NULL
3P	NULL
)	NULL
,	NULL
having	NULL
two	NULL
and	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
pFIL-4	NULL
(	NULL
3P	NULL
)	NULL
showed	NULL
comparable	NULL
activity	NULL
to	NULL
pmGMLuc-96	NULL
,	NULL
which	NULL
has	NULL
a	NULL
relatively	NULL
strong	NULL
promoter	NULL
and	NULL
enhancer	NULL
system	NULL
(	NULL
17	NULL
)	NULL
.	NULL

For	NULL
further	NULL
con-firmation	NULL
,	NULL
base	NULL
substitutions	NULL
were	NULL
introduced	NULL
within	NULL
the	NULL
P	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
the	NULL
resulting	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
mutant	NULL
plasmids	NULL
with	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
P	NULL
sequence	NULL
could	NULL
not	NULL
respond	NULL
to	NULL
stimulation	NULL
.	NULL

The	NULL
one	NULL
exception	NULL
was	NULL
pF	NULL
(	NULL
84+85	NULL
)	NULL
,	NULL
which	NULL
has	NULL
substitutions	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
(	NULL
positions	NULL
-79	NULL
to	NULL
-77	NULL
)	NULL
.	NULL

Cells	NULL
with	NULL
pF	NULL
(	NULL
72+73	NULL
)	NULL
,	NULL
in	NULL
which	NULL
base	NULL
substitutions	NULL
were	NULL
outside	NULL
the	NULL
P	NULL
sequence	NULL
,	NULL
were	NULL
responsive	NULL
to	NULL
stimulation	NULL
.	NULL

pFIL-4	NULL
(	NULL
3P	NULL
;	NULL
4	NULL
)	NULL
carrying	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
with	NULL
a	NULL
substitution	NULL
mutation	NULL
at	NULL
the	NULL
second	NULL
base	NULL
from	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
(	NULL
at	NULL
position	NULL
-70	NULL
)	NULL
could	NULL
not	NULL
respond	NULL
to	NULL
the	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
plasmid	NULL
pFIL-4	NULL
(	NULL
3P	NULL
;	NULL
)	NULL
with	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
carrying	NULL
a	NULL
substitution	NULL
mutation	NULL
at	NULL
the	NULL
second	NULL
base	NULL
from	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
(	NULL
at	NULL
position	NULL
-78	NULL
)	NULL
showed	NULL
perfect	NULL
response	NULL
to	NULL
stimulation	NULL
,	NULL
indicating	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

DNA	NULL
Binding	NULL
Protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
Recognizes	NULL
the	NULL
P	NULL
Sequence	NULL
of	NULL
the	NULL
Human	NULL
IL-4	NULL
Enhancer	NULL
.	NULL

DNA	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
specifically	NULL
recognize	NULL
the	NULL
P	NULL
sequence	NULL
and	NULL
mediate	NULL
signals	NULL
were	NULL
characterized	NULL
by	NULL
DNA-mobility-shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

When	NULL
fragment	NULL
C	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
three	NULL
distinct	NULL
shifted	NULL
bands	NULL
(	NULL
bands	NULL
I	NULL
,	NULL
II	NULL
,	NULL
and	NULL
III	NULL
)	NULL
were	NULL
observed	NULL
.	NULL

Since	NULL
their	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
addition	NULL
of	NULL
fragment	NULL
C	NULL
as	NULL
a	NULL
competitor	NULL
,	NULL
bands	NULL
I	NULL
and	NULL
II	NULL
were	NULL
considered	NULL
to	NULL
be	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
band	NULL
III	NULL
is	NULL
a	NULL
nonspecific	NULL
complex	NULL
due	NULL
to	NULL
the	NULL
failure	NULL
of	NULL
fragment	NULL
C	NULL
to	NULL
inhibit	NULL
complex	NULL
formation	NULL
.	NULL

Band	NULL
II	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
whose	NULL
recognition	NULL
sequence	NULL
resides	NULL
Table	NULL
2	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
minimum	NULL
essential	NULL
cis-acting	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
enhancer	NULL
that	NULL
mediates	NULL
PMA/A23187	NULL
stimulation	NULL
Luciferase	NULL
activity	NULL
,	NULL
units/10	NULL
ug	NULL
of	NULL
protein	NULL
Plasmid	NULL
No	NULL
stimulation	NULL
PMA/A23187	NULL
pmGMLuc-60	NULL
230	NULL
670	NULL
pFIL-4	NULL
(	NULL
176	NULL
)	NULL
140	NULL
3080	NULL
pFIL-4	NULL
(	NULL
A+B	NULL
)	NULL
200	NULL
460	NULL
pFIL-4	NULL
(	NULL
B+C	NULL
)	NULL
190	NULL
4170	NULL
pFIL-4	NULL
(	NULL
A	NULL
)	NULL
140	NULL
700	NULL
pFIL-4	NULL
(	NULL
B	NULL
)	NULL
230	NULL
1380	NULL
pFIL-4	NULL
(	NULL
C	NULL
)	NULL
180	NULL
3910	NULL
pFIL-4	NULL
(	NULL
-C	NULL
)	NULL
250	NULL
2610	NULL
pFIL-4	NULL
(	NULL
N	NULL
)	NULL
210	NULL
2120	NULL
pFIL-4	NULL
(	NULL
P	NULL
)	NULL
260	NULL
2480	NULL
2866	NULL
Immunology	NULL
:	NULL
Abe	NULL
et	NULL
al	NULL
.	NULL

A	NULL
P	NULL
Mutants	NULL
18	NULL
e	NULL
pFIL4	NULL
(	NULL
C	NULL
)	NULL
_	NULL
Gate	NULL
eTeacteacaatcreeTeTaAbeaaaatTrccaatet	NULL
.	NULL

I	NULL
i	NULL
caTaATcTceaG	NULL
pF	NULL
(	NULL
72+73	NULL
)	NULL
cataTcrecaG	NULL
)	NULL
10	NULL
pF	NULL
(	NULL
80+81	NULL
)	NULL
pF	NULL
(	NULL
82+83	NULL
)	NULL
pF	NULL
(	NULL
84+85	NULL
)	NULL
Ice	NULL
B	NULL
_	NULL
6000	NULL
M	NULL
Cont	NULL
PMA+Ca	NULL
5000	NULL
1	NULL
4000	NULL
4	NULL
3000	NULL
7	NULL
2000	NULL
7	NULL
Luciferase	NULL
Activity	NULL
units/10	NULL
ug	NULL
protein	NULL
1000	NULL
;	NULL
pmGM60	NULL
phIL-4	NULL
(	NULL
C	NULL
)	NULL
pF	NULL
(	NULL
70+71	NULL
)	NULL
pF	NULL
(	NULL
72+73	NULL
)	NULL
pF	NULL
(	NULL
80+81	NULL
)	NULL
pF	NULL
(	NULL
82+83	NULL
)	NULL
pF	NULL
(	NULL
84+85	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Substitution	NULL
mutation	NULL
analysis	NULL
within	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Synthetic	NULL
oligonucleotides	NULL
covering	NULL
fragment	NULL
C	NULL
with	NULL
3-	NULL
or	NULL
4-bp	NULL
substitutions	NULL
were	NULL
used	NULL
for	NULL
construction	NULL
of	NULL
mutant	NULL
plasmids	NULL
.	NULL

The	NULL
oligonucleotides	NULL
indicated	NULL
were	NULL
upper-strand	NULL
sequences	NULL
with	NULL
artificially	NULL
added	NULL
restriction	NULL
sites	NULL
(	NULL
GATC	NULL
)	NULL
.	NULL

The	NULL
construction	NULL
procedure	NULL
was	NULL
the	NULL
same	NULL
as	NULL
for	NULL
pFIL-4	NULL
(	NULL
C	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Luciferase	NULL
activity	NULL
of	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
various	NULL
mutant	NULL
plasmids	NULL
.	NULL

outside	NULL
the	NULL
P	NULL
sequence	NULL
,	NULL
since	NULL
it	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
fragments	NULL
N	NULL
and	NULL
P.	NULL
When	NULL
fragment	NULL
N	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
two	NULL
bands	NULL
were	NULL
observed	NULL
.	NULL

The	NULL
slower	NULL
migrating	NULL
band	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
specific	NULL
complex	NULL
,	NULL
since	NULL
formation	NULL
of	NULL
this	NULL
band	NULL
was	NULL
inhibited	NULL
by	NULL
addition	NULL
of	NULL
fragments	NULL
N	NULL
and	NULL
P	NULL
,	NULL
fragments	NULL
carrying	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

NF	NULL
(	NULL
P	NULL
)	NULL
complex	NULL
formation	NULL
,	NULL
with	NULL
the	NULL
same	NULL
specificity	NULL
,	NULL
was	NULL
observed	NULL
when	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
were	NULL
used	NULL
instead	NULL
of	NULL
the	NULL
extracts	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
relation	NULL
between	NULL
specific	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
and	NULL
expression	NULL
in	NULL
vivo	NULL
,	NULL
competition	NULL
experiments	NULL
employing	NULL
the	NULL
same	NULL
set	NULL
of	NULL
mutant	NULL
oligonucleotides	NULL
used	NULL
for	NULL
transfection	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
DNA-protein	NULL
1000	NULL
+	NULL
2	NULL
'	NULL
C	NULL
3	NULL
soo+	NULL
£	NULL
J	NULL
£	NULL
s	NULL
s00+	NULL
o	NULL
G	NULL
©	NULL
#	NULL
&	NULL
&	NULL
400+	NULL
'	NULL
o	NULL
3	NULL
_	NULL
]	NULL
200+	NULL
&	NULL
s	NULL
p	NULL
~	NULL
al	NULL
g	NULL
$	NULL
p	NULL
5	NULL
&	NULL
$	NULL
Z	NULL
C	NULL
C	NULL
4	NULL
£	NULL
#	NULL
&	NULL
$	NULL
3	NULL
v	NULL
a	NULL
r	NULL
&	NULL
&	NULL
S	NULL
¥	NULL
ZSC	NULL
#	NULL
oo	NULL
__	NULL
pF	NULL
2	NULL
2	NULL
¢	NULL
_	NULL
4	NULL
¢	NULL
gp	NULL
o	NULL
<	NULL
<	NULL
<	NULL
<	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
with	NULL
fusion	NULL
promoter	NULL
.	NULL

Plasmid	NULL
DNAs	NULL
as	NULL
indicated	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
and	NULL
cells	NULL
were	NULL
either	NULL
stimulated	NULL
by	NULL
PMA/A23187	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
or	NULL
left	NULL
unstimulated	NULL
(	NULL
hatched	NULL
bars	NULL
)	NULL
.	NULL

Activities	NULL
per	NULL
10	NULL
ug	NULL
of	NULL
extracts	NULL
are	NULL
shown	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
s2P-probe	NULL
0.4	NULL
ng	NULL
)	NULL
—C	NULL
-	NULL
N	NULL
competitors	NULL
2	NULL
x	NULL
2	NULL
®	NULL
C	NULL
NP	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
-	NULL
C	NULL
N	NULL
P	NULL
i-	NULL
&	NULL
Free	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

DNA	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
specifically	NULL
recognize	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

Fragments	NULL
C	NULL
,	NULL
N	NULL
,	NULL
and	NULL
P	NULL
,	NULL
defined	NULL
in	NULL
the	NULL
text	NULL
,	NULL
are	NULL
indicated	NULL
when	NULL
used	NULL
.	NULL

complex	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
was	NULL
inhibited	NULL
by	NULL
addition	NULL
of	NULL
50-fold	NULL
excess	NULL
of	NULL
double-stranded	NULL
oligonucleotides	NULL
72+73	NULL
and	NULL
84+85	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
70+71	NULL
,	NULL
80+81	NULL
,	NULL
and	NULL
82	NULL
+83	NULL
could	NULL
not	NULL
prevent	NULL
the	NULL
formation	NULL
of	NULL
P-labeled	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
in	NULL
vivo	NULL
transfection	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
recognition	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
by	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
IL-4	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
P	NULL
Sequence	NULL
Conserved	NULL
in	NULL
Mouse	NULL
and	NULL
Human	NULL
IL-4	NULL
Is	NULL
Apparently	NULL
Unique	NULL
to	NULL
the	NULL
IL-4	NULL
Enhancer	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
that	NULL
was	NULL
mapped	NULL
as	NULL
a	NULL
cis-acting	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
enhancer	NULL
shares	NULL
high	NULL
homology	NULL
with	NULL
the	NULL
mouse	NULL
IL-4	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
human	NULL
IL-4	NULL
enhancer	NULL
contains	NULL
two	NULL
extra	NULL
bases	NULL
(	NULL
positions	NULL
-77	NULL
and	NULL
-78	NULL
,	NULL
CG	NULL
)	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
that	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
dispensable	NULL
for	NULL
both	NULL
binding	NULL
and	NULL
transcription	NULL
activity	NULL
in	NULL
vivo	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
mouse	NULL
IL-4	NULL
enhancer	NULL
has	NULL
an	NULL
extra	NULL
base	NULL
at	NULL
position	NULL
-71	NULL
(	NULL
T	NULL
)	NULL
.	NULL

NF	NULL
(	NULL
P	NULL
)	NULL
-P-sequence	NULL
(	NULL
human	NULL
)	NULL
complex	NULL
formation	NULL
was	NULL
inhibited	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
mouse	NULL
P	NULL
sequence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
P	NULL
sequence	NULL
from	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
are	NULL
recognized	NULL
by	NULL
human	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
protein	NULL
.	NULL

As	NULL
was	NULL
indicated	NULL
(	NULL
18	NULL
)	NULL
,	NULL
reasonable	NULL
homology	NULL
was	NULL
recognized	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
genes	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
,	NULL
however	NULL
,	NULL
was	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
IL-4	NULL
enhancer	NULL
,	NULL
although	NULL
surrounding	NULL
sequences	NULL
showed	NULL
high	NULL
homology	NULL
with	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer	NULL
(	NULL
positions	NULL
-66	NULL
and	NULL
-95	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
recognition	NULL
sequence	NULL
for	NULL
NFIL2A	NULL
(	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
)	NULL
is	NULL
also	NULL
found	NULL
in	NULL
the	NULL
IL-4	NULL
Competitors	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Sequence	NULL
specificity	NULL
for	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
binding	NULL
.	NULL

DNA-mobility-shift	NULL
assays	NULL
using	NULL
oligonucleotides	NULL
containing	NULL
fragment	NULL
C	NULL
as	NULL
the	NULL
probe	NULL
and	NULL
oligonucleotides	NULL
with	NULL
[	NULL
pF	NULL
(	NULL
70+71	NULL
)	NULL
,	NULL
pF	NULL
(	NULL
72+73	NULL
)	NULL
,	NULL
etc	NULL
.	NULL

,	NULL
indicated	NULL
as	NULL
70+71	NULL
,	NULL
72+73	NULL
,	NULL
etc	NULL
.	NULL

,	NULL
respectively	NULL
]	NULL
and	NULL
without	NULL
(	NULL
fragments	NULL
C	NULL
and	NULL
N	NULL
)	NULL
substitution	NULL
mutations	NULL
as	NULL
competitors	NULL
.	NULL

-	NULL
,	NULL
None	NULL
added	NULL
.	NULL

Immunology	NULL
:	NULL
Abe	NULL
et	NULL
al	NULL
.	NULL

113	NULL
105	NULL
1	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
2867	NULL
.	NULL

+	NULL
E	NULL
G/A	NULL
A	NULL
AJA	NULL
TT	NULL
T/-	NULL
-	NULL
-	NULL
>	NULL
>	NULL
TEATIIT	NULL
cc	NULL
hIL-5	NULL
-8|O	NULL
-60	NULL
I	NULL
mIL-4	NULL
T	NULL
s	NULL
*C	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
sur-	NULL
A	NULL
Tet	NULL
Gle	NULL
[	NULL
TG	NULL
TA	NULL
Alciela	NULL
A	NULL
Ala	NULL
1	NULL
T	NULL
Tlc	NULL
c	NULL
AA	NULL
TaTAAAlc	NULL
TE	NULL
ATT	NULL
c	NULL
hIL-4	NULL
_	NULL
rounding	NULL
sequence	NULL
of	NULL
IL-4	NULL
P	NULL
se	NULL
P-sequence	NULL
-	NULL
'	NULL
90	NULL
-~73	NULL
-66	NULL
s	NULL
...	NULL
mime	NULL
_|	NULL
[	NULL
Telalaka	NULL
[	NULL
ref	NULL
afta	NULL
alra	NULL
)	NULL
ro	NULL
T	NULL
a	NULL
Aja	NULL
)	NULL
a	NULL
EAT	NULL
Tal	NULL
]	NULL
-	NULL
Site	NULL
A	NULL
'	NULL
-73	NULL
-51	NULL
1	NULL
A	NULL
a	NULL
~	NULL
Fete	NULL
)	NULL
a	NULL
BAe	NULL
Eran	NULL
enhancer	NULL
(	NULL
positions	NULL
-60	NULL
and	NULL
-91	NULL
)	NULL
but	NULL
it	NULL
is	NULL
interrupted	NULL
by	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
Different	NULL
Set	NULL
of	NULL
Proteins	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
IL-4	NULL
and	NULL
IL-2	NULL
Gene	NULL
Expression	NULL
.	NULL

Since	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
is	NULL
generally	NULL
mutually	NULL
exclusive	NULL
in	NULL
the	NULL
mouse	NULL
system	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
different	NULL
sets	NULL
of	NULL
binding	NULL
proteins	NULL
recognize	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
sequences	NULL
.	NULL

Competition	NULL
experiments	NULL
using	NULL
a	NULL
site	NULL
A	NULL
fragment	NULL
[	NULL
hIL2	NULL
(	NULL
W	NULL
)	NULL
]	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
site	NULL
A	NULL
fragments	NULL
with	NULL
various	NULL
lengths	NULL
of	NULL
insertion	NULL
sequences	NULL
as	NULL
competitors	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
hIL2	NULL
(	NULL
W	NULL
)	NULL
-NFIL2ZA	NULL
complex	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
hIL-4	NULL
(	NULL
W	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Left	NULL
)	NULL
.	NULL

When	NULL
mutant	NULL
oligonucleotides	NULL
carrying	NULL
insertions	NULL
of	NULL
partial	NULL
P	NULL
sequences	NULL
in	NULL
site	NULL
A	NULL
[	NULL
hIL2.4	NULL
(	NULL
A	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
(	NULL
C	NULL
)	NULL
]	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
,	NULL
competition	NULL
was	NULL
much	NULL
less	NULL
efficient	NULL
than	NULL
it	NULL
was	NULL
when	NULL
hIL-2	NULL
(	NULL
W	NULL
)	NULL
was	NULL
used	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
NFIL2A	NULL
protein	NULL
with	NULL
site	NULL
A	NULL
was	NULL
abolished	NULL
by	NULL
interruption	NULL
of	NULL
site	NULL
A	NULL
sequence	NULL
either	NULL
with	NULL
the	NULL
P	NULL
sequence	NULL
or	NULL
a	NULL
nonrelated	NULL
sequence	NULL
.	NULL

Binding	NULL
of	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
to	NULL
the	NULL
P	NULL
sequence	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
hIL2	NULL
(	NULL
W	NULL
)	NULL
or	NULL
by	NULL
hIL2.4	NULL
(	NULL
C	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Right	NULL
)	NULL
.	NULL

NFP	NULL
)	NULL
binding	NULL
,	NULL
however	NULL
,	NULL
was	NULL
inhibited	NULL
not	NULL
only	NULL
by	NULL
hIL4	NULL
(	NULL
W	NULL
)	NULL
but	NULL
also	NULL
by	NULL
hIL2.4	NULL
(	NULL
A	NULL
)	NULL
and	NULL
hIL2.4	NULL
(	NULL
B	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
insertions	NULL
within	NULL
the	NULL
site	NULL
A	NULL
sequence	NULL
.	NULL

This	NULL
insert	NULL
recreated	NULL
8	NULL
bp	NULL
(	NULL
AATTTCCA	NULL
)	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

Thus	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
P	NULL
sequence	NULL
is	NULL
unique	NULL
to	NULL
IL-4	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
NFP	NULL
)	NULL
but	NULL
not	NULL
by	NULL
NFIL2A	NULL
protein	NULL
,	NULL
in	NULL
spite	NULL
of	NULL
the	NULL
conservation	NULL
of	NULL
the	NULL
NFIL2A	NULL
recognition	NULL
sequence	NULL
in	NULL
the	NULL
IL-4	NULL
enhancer	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
studied	NULL
the	NULL
mechanism	NULL
of	NULL
IL-4	NULL
induction	NULL
after	NULL
T-cell	NULL
activation	NULL
as	NULL
a	NULL
model	NULL
system	NULL
for	NULL
coordinated	NULL
and	NULL
differential	NULL
regulation	NULL
of	NULL
lymphokine	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
cis-acting	NULL
DNA	NULL
element	NULL
that	NULL
responds	NULL
to	NULL
the	NULL
signal	NULL
resides	NULL
in	NULL
the	NULL
5	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
;	NULL
although	NULL
,	NULL
the	NULL
response	NULL
to	NULL
signaling	NULL
is	NULL
much	NULL
weaker	NULL
than	NULL
for	NULL
other	NULL
lymphokine	NULL
genes	NULL
such	NULL
as	NULL
GM-CSF	NULL
and	NULL
IL-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
a	NULL
reasonable	NULL
assumption	NULL
that	NULL
enhancer	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
may	NULL
be	NULL
located	NULL
not	NULL
only	NULL
in	NULL
the	NULL
5	NULL
'	NULL
upstream	NULL
sequence	NULL
but	NULL
also	NULL
in	NULL
the	NULL
intron	NULL
sequences	NULL
or	NULL
even	NULL
outside	NULL
the	NULL
IL-4	NULL
gene	NULL
,	NULL
since	NULL
genes	NULL
for	NULL
IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
are	NULL
clustered	NULL
within	NULL
several	NULL
hundred	NULL
kilobases	NULL
on	NULL
chromosomes	NULL
5	NULL
and	NULL
11	NULL
for	NULL
human	NULL
and	NULL
mouse	NULL
,	NULL
respectively	NULL
(	NULL
11	NULL
)	NULL
.	NULL

During	NULL
the	NULL
course	NULL
of	NULL
DNA	NULL
sequencing	NULL
studies	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
,	NULL
potential	NULL
enhancer	NULL
sequences	NULL
such	NULL
as	NULL
a	NULL
TG	NULL
repeat	NULL
sequence	NULL
in	NULL
the	NULL
second	NULL
intron	NULL
(	NULL
positions	NULL
2966	NULL
and	NULL
3077	NULL
)	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
form	NULL
left-handed	NULL
Z-DNA	NULL
under	NULL
certain	NULL
conditions	NULL
,	NULL
and	NULL
three	NULL
70-bp	NULL
tandem	NULL
repeats	NULL
in	NULL
intron	NULL
3	NULL
(	NULL
positions	NULL
7694	NULL
and	NULL
7902	NULL
)	NULL
were	NULL
found	NULL
.	NULL

We	NULL
,	NULL
however	NULL
,	NULL
did	NULL
not	NULL
find	NULL
any	NULL
enhancer	NULL
activity	NULL
,	NULL
when	NULL
intron	NULL
fragments	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
plasmid	NULL
phIL-4	NULL
(	NULL
176	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
an	NULL
essential	NULL
cis-acting	NULL
sequence	NULL
in	NULL
the	NULL
T-cell	NULL
leukemia	NULL
cell	NULL
line	NULL
Jurkat	NULL
between	NULL
positions	NULL
-176	NULL
and	NULL
-63	NULL
by	NULL
using	NULL
5	NULL
'	NULL
deletion	NULL
constructs	NULL
.	NULL

The	NULL
observation	NULL
was	NULL
quence	NULL
with	NULL
T	NULL
;	NULL
l	NULL
and	NULL
T	NULL
»	NULL
,2	NULL
lymphokine	NULL
genes	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
common	NULL
to	NULL
IL-2	NULL
and	NULL
IL-4	NULL
,	NULL
IL-2	NULL
and	NULL
interferon	NULL
y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
and	NULL
IL-4	NULL
and	NULL
IL-5	NULL
are	NULL
boxed	NULL
with	NULL
different	NULL
shadings	NULL
.	NULL

m	NULL
,	NULL
Mouse	NULL
;	NULL
h	NULL
,	NULL
human	NULL
.	NULL

hIL-2	NULL
JGG	NULL
@	NULL
T	NULL
_	NULL
hIFN-y	NULL
also	NULL
confirmed	NULL
in	NULL
a	NULL
human	NULL
T-cell	NULL
clone	NULL
,	NULL
B21	NULL
(	NULL
16	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
mapped	NULL
a	NULL
P	NULL
sequence	NULL
(	NULL
CGAAAATTTCC	NULL
;	NULL
between	NULL
positions	NULL
-79	NULL
and	NULL
-69	NULL
from	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
)	NULL
as	NULL
a	NULL
cis-acting	NULL
sequence	NULL
.	NULL

An	NULL
experiment	NULL
using	NULL
substitution	NULL
mutations	NULL
in	NULL
the	NULL
P	NULL
sequence	NULL
confirmed	NULL
that	NULL
this	NULL
sequence	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
PMA/A23187-stimulated	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
evidence	NULL
that	NULL
transcription	NULL
activity	NULL
was	NULL
augmented	NULL
by	NULL
placing	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
P	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
basic	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
also	NULL
supports	NULL
this	NULL
proposal	NULL
.	NULL

The	NULL
P	NULL
sequence	NULL
is	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
IL-4	NULL
gene	NULL
and	NULL
was	NULL
conserved	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
,	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
,	NULL
that	NULL
recognizes	NULL
the	NULL
P	NULL
sequence	NULL
specifically	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
competition	NULL
experiment	NULL
showed	NULL
that	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
can	NULL
recognize	NULL
human	NULL
and	NULL
mouse	NULL
P	NULL
sequences	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
-DNA	NULL
complex	NULL
,	NULL
however	NULL
,	NULL
was	NULL
not	NULL
PMA/	NULL
A23187-stimulation-dependent	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
for	NULL
this	NULL
observation	NULL
.	NULL

For	NULL
ex-ample	NULL
,	NULL
the	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
binds	NULL
to	NULL
unidentified	NULL
polypeptide	NULL
(	NULL
s	NULL
)	NULL
whose	NULL
32	NULL
P-probe	NULL
)	NULL
ay	NULL
mew	NULL
_	NULL
mew	NULL
.	NULL

a	NULL
&	NULL
<	NULL
T	NULL
M	NULL
O	NULL
a	NULL
a	NULL
T	NULL
M	NULL
O	NULL
~	NULL
competitors	NULL
S	NULL
Y	NULL
Y	NULL
8	NULL
%	NULL
3	NULL
3	NULL
Q	NULL
9	NULL
8	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
-	NULL
<	NULL
<	NULL
<	NULL
c	NULL
C	NULL
-	NULL
€	NULL
E	NULL
C	NULL
EC	NULL
NFIL2AA	NULL
.	NULL

Auk	NULL
buh	NULL
bad	NULL
Yh	NULL
n-nHH-n-	NULL
-	NULL
Free	NULL
Free	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Different	NULL
sets	NULL
of	NULL
proteins	NULL
recognize	NULL
the	NULL
IL-4	NULL
and	NULL
IL-2	NULL
enhancers	NULL
.	NULL

Conditions	NULL
for	NULL
mobility-shift	NULL
assays	NULL
were	NULL
as	NULL
indicated	NULL
.	NULL

Oligongcélzeotides	NULL
used	NULL
for	NULL
this	NULL
experiment	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
hIL4	NULL
(	NULL
W	NULL
)	NULL
,	NULL
GaATC	NULL
CAATCTGGTGTAACGAAAATTTCCAATGTAAACT-CATTT	NULL
;	NULL
hIL2	NULL
(	NULL
W	NULL
)	NULL
,	NULL
GATC	NULL
AAAATATGTGTAATATGTAAAACA-	NULL
T-TTT	NULL
;	NULL
hIL2.4	NULL
(	NULL
A	NULL
)	NULL
,	NULL
GATCAAAATATGTGTAATITCCATG-TAAAACATTTT	NULL
;	NULL
hIL2.4	NULL
(	NULL
B	NULL
)	NULL
,	NULL
GATCAAAATATGTGTAATAAAT-TCCATGTAAAACATTTT	NULL
;	NULL
hIL2.4	NULL
(	NULL
C	NULL
)	NULL
,	NULL
GATCAAAATATG-TGTAATATCTGCAGATGTAAAACATTTT	NULL
.	NULL

The	NULL
underlined	NULL
sequences	NULL
(	NULL
GATC	NULL
)	NULL
represent	NULL
artificially	NULL
added	NULL
restriction	NULL
sites	NULL
.	NULL

Boldface	NULL
type	NULL
represents	NULL
the	NULL
P	NULL
sequence	NULL
and	NULL
underlined	NULL
boldface	NULL
type	NULL
represents	NULL
either	NULL
a	NULL
part	NULL
of	NULL
the	NULL
IL-4	NULL
or	NULL
unrelated	NULL
sequence	NULL
inserted	NULL
into	NULL
the	NULL
hIL2CW	NULL
)	NULL
sequence	NULL
.	NULL

Position	NULL
numbers	NULL
indicate	NULL
positions	NULL
from	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
or	NULL
IL-4	NULL
gene	NULL
.	NULL

2868	NULL
Immunology	NULL
:	NULL
Abe	NULL
et	NULL
al	NULL
.	NULL

interaction	NULL
is	NULL
stimulation-dependent	NULL
but	NULL
whose	NULL
affinity	NULL
to	NULL
NFP	NULL
)	NULL
is	NULL
not	NULL
strong	NULL
enough	NULL
to	NULL
allow	NULL
isolation	NULL
as	NULL
a	NULL
complex	NULL
by	NULL
a	NULL
mobility-shift	NULL
assay	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
is	NULL
modified	NULL
in	NULL
a	NULL
stimulation-dependent	NULL
manner	NULL
but	NULL
the	NULL
modification	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
mobility-shift	NULL
band	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
region	NULL
surrounding	NULL
the	NULL
P	NULL
sequence	NULL
(	NULL
positions	NULL
-91	NULL
to	NULL
-53	NULL
)	NULL
of	NULL
human	NULL
IL-4	NULL
showed	NULL
high	NULL
homology	NULL
(	NULL
88	NULL
%	NULL
)	NULL
with	NULL
the	NULL
site	NULL
A	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
(	NULL
positions	NULL
-91	NULL
to	NULL
-66	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

NFIL2A	NULL
,	NULL
which	NULL
recognizes	NULL
site	NULL
A	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
19	NULL
)	NULL
,	NULL
is	NULL
indistinguishable	NULL
from	NULL
the	NULL
ubiquitous	NULL
octamer	NULL
binding	NULL
protein	NULL
Oct-1	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Two	NULL
octamer	NULL
motifs	NULL
,	NULL
ATGCAAAG	NULL
(	NULL
positions	NULL
-302	NULL
to	NULL
-295	NULL
)	NULL
and	NULL
ATGTAAA	NULL
(	NULL
C	NULL
)	NULL
T	NULL
[	NULL
positions	NULL
-67	NULL
to	NULL
-60	NULL
(	NULL
-59	NULL
)	NULL
]	NULL
,	NULL
are	NULL
recognized	NULL
in	NULL
the	NULL
human	NULL
IL-4	NULL
enhancer	NULL
.	NULL

The	NULL
former	NULL
octamer	NULL
motif	NULL
,	NULL
however	NULL
,	NULL
is	NULL
found	NULL
only	NULL
in	NULL
human	NULL
IL-4	NULL
.	NULL

The	NULL
latter	NULL
octamer	NULL
motif	NULL
seems	NULL
not	NULL
to	NULL
be	NULL
recognized	NULL
by	NULL
Oct-1	NULL
protein	NULL
in	NULL
spite	NULL
of	NULL
good	NULL
conservation	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
,	NULL
since	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
hIL-4	NULL
(	NULL
W	NULL
)	NULL
fragment	NULL
(	NULL
positions	NULL
-92	NULL
to	NULL
-53	NULL
)	NULL
did	NULL
not	NULL
inhibit	NULL
NFIL2A	NULL
(	NULL
Oct-1	NULL
)	NULL
-site	NULL
A	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
indicated	NULL
that	NULL
,	NULL
in	NULL
IL-4	NULL
,	NULL
insertion	NULL
of	NULL
a	NULL
P	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
octamer	NULL
motif	NULL
abolishes	NULL
the	NULL
interaction	NULL
between	NULL
NFIL2A	NULL
(	NULL
Oct-1	NULL
)	NULL
and	NULL
DNA	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
octamer	NULL
consensus	NULL
motif	NULL
alone	NULL
may	NULL
not	NULL
be	NULL
enough	NULL
for	NULL
NFIL2A	NULL
(	NULL
Oct-1	NULL
)	NULL
protein	NULL
recognition	NULL
.	NULL

Thus	NULL
this	NULL
may	NULL
be	NULL
a	NULL
device	NULL
by	NULL
which	NULL
Oct-1	NULL
protein	NULL
,	NULL
a	NULL
ubiquitous	NULL
protein	NULL
,	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
IL-2	NULL
enhancer	NULL
but	NULL
not	NULL
with	NULL
the	NULL
IL-4	NULL
enhancer	NULL
.	NULL

Unlike	NULL
IL-2	NULL
,	NULL
the	NULL
IL-4	NULL
enhancer	NULL
requires	NULL
only	NULL
a	NULL
short	NULL
stretch	NULL
of	NULL
the	NULL
DNA	NULL
motif	NULL
(	NULL
P	NULL
sequence	NULL
)	NULL
to	NULL
confer	NULL
responsiveness	NULL
to	NULL
PMA/A23187	NULL
stimulation	NULL
.	NULL

For	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
at	NULL
least	NULL
four	NULL
and	NULL
possibly	NULL
five	NULL
motifs	NULL
within	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
positions	NULL
-326	NULL
to	NULL
-63	NULL
)	NULL
seem	NULL
to	NULL
be	NULL
involved	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Among	NULL
several	NULL
DNA	NULL
binding	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
critical	NULL
sites	NULL
for	NULL
IL-2	NULL
expression	NULL
,	NULL
such	NULL
as	NULL
NF-AT	NULL
,	NULL
NFIL2A	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
AP-1	NULL
(	NULL
21-23	NULL
)	NULL
,	NULL
NF-AT	NULL
,	NULL
which	NULL
binds	NULL
at	NULL
the	NULL
E	NULL
site	NULL
(	NULL
extend-ing	NULL
from	NULL
positions	NULL
-255	NULL
to	NULL
-285	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
)	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
provide	NULL
activation	NULL
dependency	NULL
and	NULL
T-cell	NULL
specificity	NULL
(	NULL
22	NULL
)	NULL
.	NULL

For	NULL
IL-4	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
the	NULL
P	NULL
sequence	NULL
alone	NULL
is	NULL
enough	NULL
to	NULL
confer	NULL
T-cell	NULL
specificity	NULL
and	NULL
activation	NULL
dependency	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
the	NULL
IL-4	NULL
gene	NULL
is	NULL
induced	NULL
by	NULL
p40'*	NULL
and	NULL
by	NULL
PMA/A23187	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
share	NULL
the	NULL
same	NULL
cis-acting	NULL
sequence	NULL
,	NULL
the	NULL
P	NULL
sequence	NULL
.	NULL

Several	NULL
groups	NULL
have	NULL
claimed	NULL
that	NULL
p40'**	NULL
acts	NULL
through	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
related	NULL
proteins	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
the	NULL
IL-2	NULL
receptor	NULL
is	NULL
proposed	NULL
(	NULL
25-29	NULL
)	NULL
.	NULL

From	NULL
that	NULL
evidence	NULL
,	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
a	NULL
NF-	NULL
«	NULL
B-related	NULL
protein	NULL
,	NULL
but	NULL
a	NULL
definitive	NULL
answer	NULL
is	NULL
not	NULL
yet	NULL
available	NULL
.	NULL

Since	NULL
,	NULL
unlike	NULL
NF-KB	NULL
,	NULL
binding	NULL
of	NULL
the	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
is	NULL
not	NULL
stimulation-dependent	NULL
,	NULL
although	NULL
an	NULL
excess	NULL
amount	NULL
of	NULL
«	NULL
B	NULL
oligonucleotide	NULL
abolished	NULL
the	NULL
complex	NULL
of	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
with	NULL
P-sequence	NULL
probe	NULL
(	NULL
unpublished	NULL
result	NULL
)	NULL
.	NULL

Many	NULL
human	NULL
T-cell	NULL
clones	NULL
are	NULL
found	NULL
to	NULL
simultaneously	NULL
secrete	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
interferon	NULL
y	NULL
upon	NULL
stimulation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
human	NULL
counterparts	NULL
of	NULL
the	NULL
mouse	NULL
T	NULL
,	NULL
,1	NULL
and	NULL
T	NULL
,	NULL
,2	NULL
subsets	NULL
,	NULL
with	NULL
similar	NULL
cytokine	NULL
production	NULL
profiles	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
among	NULL
T-cell	NULL
clones	NULL
isolated	NULL
in	NULL
certain	NULL
disease	NULL
situations	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
human	NULL
T,1-like	NULL
subset	NULL
produced	NULL
IL-2	NULL
and	NULL
interferon	NULL
y	NULL
but	NULL
low	NULL
or	NULL
absent	NULL
levels	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
,	NULL
whereas	NULL
the	NULL
T	NULL
,	NULL
,2-like	NULL
subset	NULL
had	NULL
the	NULL
opposite	NULL
pattern	NULL
,	NULL
indicating	NULL
that	NULL
under	NULL
particular	NULL
conditions	NULL
human	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
primed	NULL
in	NULL
vivo	NULL
to	NULL
subsets	NULL
with	NULL
a	NULL
restricted	NULL
cytokine	NULL
production	NULL
profile	NULL
.	NULL

The	NULL
results	NULL
in	NULL
this	NULL
paper	NULL
suggest	NULL
that	NULL
DNA	NULL
binding	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
genes	NULL
in	NULL
a	NULL
mutually	NULL
exclusive	NULL
way	NULL
,	NULL
therefore	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
structure	NULL
of	NULL
these	NULL
genes	NULL
may	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
T,1-	NULL
and	NULL
T	NULL
,	NULL
,2-like	NULL
cytokines	NULL
.	NULL

This	NULL
is	NULL
substantiated	NULL
by	NULL
the	NULL
DNA	NULL
sequence	NULL
comparison	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

It	NULL
remains	NULL
,	NULL
however	NULL
,	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
coupling	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
to	NULL
intracellular	NULL
signaling	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
(	NULL
1992	NULL
)	NULL
pathways	NULL
,	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
signaling	NULL
pathways	NULL
itself	NULL
(	NULL
31	NULL
)	NULL
,	NULL
or	NULL
to	NULL
the	NULL
involvement	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
thank	NULL
Ms.	NULL
P.	NULL
Hung	NULL
and	NULL
M.	NULL
Maruyama	NULL
for	NULL
preparation	NULL
of	NULL
large	NULL
scale	NULL
cultures	NULL
and	NULL
extracts	NULL
,	NULL
Mr.	NULL
F.	NULL
Vega	NULL
for	NULL
oligonucleotides	NULL
,	NULL
and	NULL
Drs	NULL
.	NULL

T.	NULL
Yokota	NULL
,	NULL
J.	NULL
Nishida	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
and	NULL
H.	NULL
Yssel	NULL
for	NULL
useful	NULL
discussions	NULL
.	NULL

DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
is	NULL
supported	NULL
by	NULL
Schering-Plough	NULL
Corp.	NULL
1	NULL
.	NULL

Noma	NULL
,	NULL
Y.	NULL
,	NULL
Sideras	NULL
,	NULL
P.	NULL
,	NULL
Naito	NULL
,	NULL
T.	NULL
,	NULL
Bergstedt-Lindquist	NULL
,	NULL
S.	NULL
,	NULL
Azuma	NULL
,	NULL
C.	NULL
,	NULL
Sverison	NULL
,	NULL
E.	NULL
,	NULL
Tanabe	NULL
,	NULL
T.	NULL
,	NULL
Kinashi	NULL
,	NULL
T.	NULL
,	NULL
Matsuda	NULL
,	NULL
F.	NULL
,	NULL
Yaoita	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Honjo	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
319	NULL
,	NULL
640-646	NULL
.	NULL

2	NULL
.	NULL

Lee	NULL
,	NULL
F.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Meyerson	NULL
,	NULL
P.	NULL
,	NULL
Villaret	NULL
,	NULL
D.	NULL
,	NULL
Coffman	NULL
,	NULL
R.	NULL
,	NULL
Mosmann	NULL
,	NULL
T.	NULL
,	NULL
Rennick	NULL
,	NULL
D.	NULL
,	NULL
Roehm	NULL
,	NULL
N.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
,	NULL
Zlotnik	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
2061-2065	NULL
.	NULL

3	NULL
.	NULL

Howard	NULL
,	NULL
M.	NULL
,	NULL
Farrar	NULL
,	NULL
J.	NULL
,	NULL
Hilfiker	NULL
,	NULL
M.	NULL
,	NULL
Johnson	NULL
,	NULL
B.	NULL
,	NULL
Takatsu	NULL
,	NULL
K.	NULL
,	NULL
Hamaoka	NULL
,	NULL
T.	NULL
&	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

155	NULL
,	NULL
914-923	NULL
.	NULL

4	NULL
.	NULL

Yokota	NULL
,	NULL
T.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
J.	NULL
,	NULL
Spits	NULL
,	NULL
H.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
Zlotnik	NULL
,	NULL
A.	NULL
,	NULL
Rennick	NULL
,	NULL
D.	NULL
,	NULL
Howard	NULL
,	NULL
M.	NULL
,	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

102	NULL
,	NULL
137-187	NULL
.	NULL

5	NULL
.	NULL

Arai	NULL
,	NULL
K.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
&	NULL
Yokota	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

59	NULL
,	NULL
783-836	NULL
.	NULL

6	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
R.	NULL
&	NULL
Coffman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
145-173	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Muramatsu	NULL
,	NULL
M.	NULL
,	NULL
Kaibuchi	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
831-836	NULL
.	NULL

8	NULL
.	NULL

Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Villaret	NULL
,	NULL
D.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
333-344	NULL
.	NULL

9	NULL
.	NULL

Arai	NULL
,	NULL
N.	NULL
,	NULL
Nomura	NULL
,	NULL
D.	NULL
,	NULL
Villaret	NULL
,	NULL
D.	NULL
,	NULL
DeWaal	NULL
Malefijt	NULL
,	NULL
R.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Minoshima	NULL
,	NULL
S.	NULL
,	NULL
Fukuyama	NULL
,	NULL
R.	NULL
,	NULL
Mackawa	NULL
,	NULL
M.	NULL
,	NULL
Kudoh	NULL
,	NULL
J.	NULL
,	NULL
Shimizu	NULL
,	NULL
N.	NULL
,	NULL
Yokota	NULL
,	NULL
K.	NULL
,	NULL
Abe	NULL
,	NULL
E.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Takebe	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
274-282	NULL
.	NULL

10	NULL
.	NULL

Lee	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Campbell	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
Kozak	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

&	NULL
Young	NULL
,	NULL
I.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Somtic	NULL
Cell	NULL
Mol	NULL
.	NULL

Genet	NULL
.	NULL

15	NULL
,	NULL
143-152	NULL
.	NULL

11	NULL
.	NULL

Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Lemons	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Espinosa	NULL
,	NULL
R.	NULL
,	NULL
III	NULL
,	NULL
Larson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
&	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
73	NULL
,	NULL
647-650	NULL
.	NULL

12	NULL
.	NULL

Abe	NULL
,	NULL
E.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
He-matopoiesis	NULL
,	NULL
eds	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
C.	NULL
&	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
Wiley-Liss	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

91-95	NULL
.	NULL

13	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
5581-5587	NULL
.	NULL

14	NULL
.	NULL

Heike	NULL
,	NULL
T.	NULL
,	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1411-1417	NULL
.	NULL

15	NULL
.	NULL

Sugimoto	NULL
,	NULL
K.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

2	NULL
,	NULL
787-794	NULL
.	NULL

16	NULL
.	NULL

Spits	NULL
,	NULL
H.	NULL
,	NULL
Touraine	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Yssel	NULL
,	NULL
H.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Ron-carolo	NULL
,	NULL
N.-G.	NULL
(	NULL
1990	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

116	NULL
,	NULL
101-116	NULL
.	NULL

17	NULL
.	NULL

Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Sugimoto	NULL
,	NULL
K.	NULL
,	NULL
Yodoi	NULL
,	NULL
J.	NULL
,	NULL
Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

3	NULL
,	NULL
807-817	NULL
.	NULL

18	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
&	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
2561-2568	NULL
.	NULL

19	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Bal-agaje	NULL
,	NULL
R.	NULL
&	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
.	NULL

20	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
&	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
.	NULL

21	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
439-464	NULL
.	NULL

22	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Utz	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Toole	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

&	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
202-205	NULL
.	NULL

23	NULL
.	NULL

Hoys	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Boehnlein	NULL
,	NULL
E.	NULL
,	NULL
Sickevitz	NULL
,	NULL
M.	NULL
&	NULL
Green	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
457-460	NULL
.	NULL

24	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
333	NULL
,	NULL
776-778	NULL
.	NULL

25	NULL
.	NULL

Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Yoneyama	NULL
,	NULL
M.	NULL
&	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

1	NULL
,	NULL
43-49	NULL
.	NULL

26	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
,	NULL
Lenardo	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
466-469	NULL
.	NULL

27	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
.	NULL

28	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
Mitomo	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.	NULL
&	NULL
Yamamoto	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
561-568	NULL
.	NULL

29	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Boehnlein	NULL
,	NULL
E.	NULL
&	NULL
Green	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2331-2335	NULL
.	NULL

30	NULL
.	NULL

-	NULL
Parronchi	NULL
,	NULL
P.	NULL
,	NULL
Macchia	NULL
,	NULL
D.	NULL
,	NULL
Piccini	NULL
,	NULL
M.-P.	NULL
,	NULL
Biswas	NULL
,	NULL
P.	NULL
,	NULL
Simo-nelli	NULL
,	NULL
C.	NULL
,	NULL
Maggi	NULL
,	NULL
E.	NULL
,	NULL
Ricci	NULL
,	NULL
M.	NULL
,	NULL
Ansari	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Romaganani	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
4538-4542	NULL
.	NULL

31	NULL
.	NULL

Novak	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

&	NULL
Rotherberg	NULL
,	NULL
E.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9353-9357	NULL
.	NULL

